Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pulmonx (LUNG) Shares Outstanding (2019 - 2025)

Pulmonx (LUNG) has disclosed Shares Outstanding for 7 consecutive years, with $41.2 million as the latest value for Q3 2025.

  • Quarterly Shares Outstanding rose 4.45% to $41.2 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $41.2 million through Sep 2025, up 4.45% year-over-year, with the annual reading at $39.8 million for FY2024, 3.3% up from the prior year.
  • Shares Outstanding for Q3 2025 was $41.2 million at Pulmonx, up from $40.7 million in the prior quarter.
  • The five-year high for Shares Outstanding was $41.2 million in Q3 2025, with the low at $35.8 million in Q1 2021.
  • Average Shares Outstanding over 5 years is $38.3 million, with a median of $38.0 million recorded in 2023.
  • The sharpest move saw Shares Outstanding soared 1635.08% in 2021, then increased 1.6% in 2022.
  • Over 5 years, Shares Outstanding stood at $36.9 million in 2021, then increased by 1.69% to $37.6 million in 2022, then rose by 2.56% to $38.5 million in 2023, then rose by 3.3% to $39.8 million in 2024, then increased by 3.67% to $41.2 million in 2025.
  • According to Business Quant data, Shares Outstanding over the past three periods came in at $41.2 million, $40.7 million, and $40.2 million for Q3 2025, Q2 2025, and Q1 2025 respectively.